{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:07:39Z","timestamp":1793606859321,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10157-025-02716-6","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T04:35:25Z","timestamp":1749789325000},"page":"1666-1669","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The epidemiology of encapsulating peritoneal sclerosis in an era of biocompatible neutral peritoneal dialysis solution in Japan"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5602-8104","authenticated-orcid":false,"given":"Yukio","family":"Maruyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanae","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudo","family":"Tanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"issue":"4","key":"2716_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0272-6386(04)00953-9","volume":"44","author":"H Kawanishi","year":"2004","unstructured":"Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis. 2004;44(4):729\u201337.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"2716_CR2","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrneph.2011.93","volume":"7","author":"MR Korte","year":"2011","unstructured":"Korte MR, Sampimon DE, Betjes MG, Krediet RT. Encapsulating peritoneal sclerosis: the state of affairs. Nat Rev Nephrol. 2011;7(9):528\u201338. https:\/\/doi.org\/10.1038\/nrneph.2011.93.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"2716_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10157-023-02360-y","volume":"27","author":"M Nakayama","year":"2023","unstructured":"Nakayama M, Miyazaki M, Hamada C, Ito Y, Honda K, Peritoneal Biopsy Study Group of the Japanese Society for Peritoneal D. Pathophysiology of encapsulating peritoneal sclerosis: lessons from findings of the past three decades in Japan. Clin Exp Nephrol. 2023;27(9):717\u201327. https:\/\/doi.org\/10.1007\/s10157-023-02360-y.","journal-title":"Clin Exp Nephrol."},{"issue":"Suppl 4","key":"2716_CR4","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1177\/089686080002004S04","volume":"20","author":"Y Kawaguchi","year":"2000","unstructured":"Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International society for peritoneal dialysis Ad Hoc committee on ultrafiltration management in peritoneal dialysis. Perit Dial Int. 2000;20(Suppl 4):S43-55.","journal-title":"Perit Dial Int"},{"key":"2716_CR5","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1046\/j.1523-1755.63.s84.18.x","volume":"84","author":"J Witowski","year":"2003","unstructured":"Witowski J, Jorres A, Korybalska K, Ksiazek K, Wisniewska-Elnur J, Bender TO, et al. Glucose degradation products in peritoneal dialysis fluids: do they harm? Kidney Int Suppl. 2003;84:S148\u201351.","journal-title":"Kidney Int Suppl"},{"issue":"9","key":"2716_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nrneph.2012.144","volume":"8","author":"A Pletinck","year":"2012","unstructured":"Pletinck A, Vanholder R, Veys N, Van Biesen W. Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions. Nat Rev Nephrol. 2012;8(9):542\u201350. https:\/\/doi.org\/10.1038\/nrneph.2012.144.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"2716_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10157-024-02564-w","volume":"29","author":"I Berke","year":"2025","unstructured":"Berke I, Barutcu Atas D, Tugcu M, Arikan H, Velioglu A, Asicioglu E. Clinical outcomes in peritoneal dialysis with refractory peritonitis: significance of the day 5 cell count. Clin Exp Nephrol. 2025;29(2):221\u20136. https:\/\/doi.org\/10.1007\/s10157-024-02564-w.","journal-title":"Clin Exp Nephrol"},{"issue":"11","key":"2716_CR8","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10157-024-02531-5","volume":"28","author":"T Sakurada","year":"2024","unstructured":"Sakurada T, Miyazaki M, Nakayama M, Ito Y. Peritoneal dialysis-related infections in elderly patients. Clin Exp Nephrol. 2024;28(11):1065\u201374. https:\/\/doi.org\/10.1007\/s10157-024-02531-5.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"2716_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10157-023-02424-z","volume":"28","author":"S Hori","year":"2024","unstructured":"Hori S, Tomizawa M, Inoue K, Yoneda T, Tachibana A, Miyamoto T, et al. Impact of nutrition and inflammation indicators on peritoneal dialysis initiation and management. Clin Exp Nephrol. 2024;28(4):349\u201358. https:\/\/doi.org\/10.1007\/s10157-023-02424-z.","journal-title":"Clin Exp Nephrol"},{"issue":"7","key":"2716_CR10","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3747\/pdi.2013.00074","volume":"34","author":"M Nakayama","year":"2014","unstructured":"Nakayama M, Miyazaki M, Honda K, Kasai K, Tomo T, Nakamoto H, et al. Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the NEXT-PD study. Perit Dial Int. 2014;34(7):766\u201374. https:\/\/doi.org\/10.3747\/pdi.2013.00074.","journal-title":"Perit Dial Int"},{"issue":"2","key":"2716_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s10157-024-02565-9","volume":"29","author":"T Nakano","year":"2025","unstructured":"Nakano T, Kitamura H, Tsuneyoshi S, Tsuchimoto A, Torisu K, Tsujikawa H, et al. Predictors of encapsulated peritoneal sclerosis in patients undergoing peritoneal dialysis using neutral-pH dialysate. Clin Exp Nephrol. 2025;29(2):212\u201320. https:\/\/doi.org\/10.1007\/s10157-024-02565-9.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"2716_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41100-024-00531-5","volume":"10","author":"N Hanafusa","year":"2024","unstructured":"Hanafusa N, Abe M, Joki N, Hoshino J, Kikuchi K, Goto S, et al. Annual dialysis data report 2020, JSDT renal data registry. Renal Replace Therapy. 2024;10(1):14. https:\/\/doi.org\/10.1186\/s41100-024-00531-5.","journal-title":"Renal Replace Therapy"},{"key":"2716_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s41100-019-0248-1","volume":"5","author":"K Nitta","year":"2019","unstructured":"Nitta K, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, et al. Annual dialysis data report 2017, JSDT renal data registry. Renal Replace Therapy. 2019;5:53. https:\/\/doi.org\/10.1186\/s41100-019-0248-1.","journal-title":"Renal Replace Therapy"},{"issue":"1","key":"2716_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1523-1755.2004.00747.x","volume":"66","author":"JD Williams","year":"2004","unstructured":"Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int. 2004;66(1):408\u201318. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00747.x.","journal-title":"Kidney Int"},{"issue":"3","key":"2716_CR15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3747\/pdi.2011.00270","volume":"33","author":"K Kawanishi","year":"2013","unstructured":"Kawanishi K, Honda K, Tsukada M, Oda H, Nitta K. Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis. Perit Dial Int. 2013;33(3):242\u201351. https:\/\/doi.org\/10.3747\/pdi.2011.00270.","journal-title":"Perit Dial Int"},{"issue":"1","key":"2716_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/ndt\/gfi188","volume":"21","author":"M Zareie","year":"2006","unstructured":"Zareie M, Keuning ED, ter Wee PM, Schalkwijk CG, Beelen RH, van den Born J. Improved biocompatibility of bicarbonate\/lactate-buffered PDF is not related to pH. Nephrol Dial Transpl. 2006;21(1):208\u201316. https:\/\/doi.org\/10.1093\/ndt\/gfi188.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"2716_CR17","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s10157-018-1602-2","volume":"22","author":"B Dioos","year":"2018","unstructured":"Dioos B, Paternot G, Jenvert RM, Duponchelle A, Marshall MR, Nakajima M, et al. Biocompatibility of a new PD solution for Japan, reguneal, measured as in vitro proliferation of fibroblasts. Clin Exp Nephrol. 2018;22(6):1427\u201336. https:\/\/doi.org\/10.1007\/s10157-018-1602-2.","journal-title":"Clin Exp Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02716-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:33:44Z","timestamp":1761708824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02716-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2716"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02716-6","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Y.M., N.M., Y.T., and M.I. received honoraria from Vantive International, Inc., and Terumo Corporation. No other authors have any conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}